Liu, G., Li, X., He, A., Li, K., Niu, H. (2025). Neoadjuvant cetuximab plus tislelizumab combined with chemotherapy in pMMR RAS/BRAF wild-type (wt) locally advanced rectal cancer (LARC): A prospective, multicenter, phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps3640